Sangamo Therapeutics Inc (SGMO) Stock Price, Quote, News & History

SGMONASDAQ

Trade with Public

$0.1284

-0.0492-27.70%

Last update: May 6, 2:48 PM

OverviewNews Earnings Options Guidance Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

Volume / Avg.

10.79M / 9.06M

Day Range

- - -

52 Wk Range

0.12 - 0.77

Market Cap

$53.19M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

Days to Cover

6.78

Recent Sangamo Therapeutics Inc News

Sangamo Therapeutics Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Sangamo Therapeutics will release Q4 earnings on March 30. Analysts predict a quarterly loss of 5 cents per share and revenue of $40.25 million.

Avi Kapoor

Sangamo Therapeutics Stock Surges After The Bell: What's Going On?

Sangamo Therapeutics shares are surging in Thursday's after-hours session after the company announced a new agreement with pharmaceutical giant Eli Lilly And Co.

Adam Eckert

Pfizer Discontinues Hemophilia Gene Therapy Beqvez As Interest Wanes

Pfizer has discontinued Beqvez for hemophilia B due to low patient demand and will focus on alternative treatments, including its approved therapy, Hympavzi.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-97.21M

Investing Cash Flow (TTM)

-102.00K

Financing Cash Flow (TTM)

70.75M

Free Cash Flow (TTM)

-97.31M

Capital Expenditure (TTM)

-102.00K

Net Change in Cash (TTM)

-26.56M

Analyst Trends and Forecast

Nov 25

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

2.8

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$52.00M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

0.79

PB Ratio (TTM)

Earnings Yield % (TTM)

-394.97%

Earnings Yield % (FWD)

-175.04%

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

-$0.03

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$20.95M

Debt to Equity

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

Volume / Avg.

10.79M / 9.06M

Day Range

- - -

52 Wk Range

0.12 - 0.77

Market Cap

$53.19M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

Days to Cover

6.78

About

Sector

N/A

Industry

N/A

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its neurology development is focuse...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Sangamo Therapeutics Inc (SGMO) stock?

You can purchase shares of Sangamo Therapeutics Inc (NASDAQ:SGMO) through any online brokerage.

View our list of the best stock brokerages

Who are Sangamo Therapeutics Inc (SGMO) competitors?

There are no as such competitors for Sangamo Therapeutics Inc.

What is the forecast, or price target, for Sangamo Therapeutics Inc (SGMO) stock?

Sangamo Therapeutics Inc has a consensus price target of $5.22.

What is the current price for Sangamo Therapeutics Inc (SGMO)?

The stock price for Sangamo Therapeutics Inc (NASDAQ: SGMO) is $0.1284 last updated May 6, 2026 at 2:48 PM EDT.

Does Sangamo Therapeutics Inc (SGMO) pay a dividend?

There are no upcoming dividends for Sangamo Therapeutics Inc.

When is Sangamo Therapeutics Inc (NASDAQ:SGMO) reporting earnings?

Sangamo Therapeutics Inc does not have any upcoming earnings scheduled.

Is Sangamo Therapeutics Inc (SGMO) going to split?

There is no upcoming split for Sangamo Therapeutics Inc.

What sector and industry does Sangamo Therapeutics Inc (SGMO) operate in?

Sangamo Therapeutics Inc is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.